Delta what? Here's how to understand the difference between Delta 8, 9 and 10
These products, sold as smokables, edible desserts, candies and soft drinks, contain "Delta 8" or "Delta 10." These products can certainly result in a "high" that is like marijuana, but they aren't fully natural and don't include the compounds associated with medical and recreational marijuana.
In 2018, President Donald Trump signed the Agriculture Improvement Act, more commonly known as the Farm Bill, which removed hemp from the 1970 Controlled Substances Act. Previously, hemp was classified as a Schedule 1 drug alongside marijuana and other heavy drugs like heroin and methamphetamemes. Simply put, hemp production, manufacturing, sale and consumption is federally legal.
Delta 8 and Delta 10 both fall under this hemp category, as long as they contain 0.3% or less THC. This means products containing Delta 8 or Delta 10 can be sold in states where medical or recreational marijuana has yet to be legalized. Alternatively, Delta 9, the compound associated with medical and recreational marijuana, contains 0.3% or more THC and is not federally legal. It is regulated state by state.
So just what is the difference between all these "Deltas"? Here's what to know about the different cannabinoids on the market.
Delta 8, Delta 9 and Delta 10 are three of the more than 100 cannabinoids, or chemicals, that exist within the cannabis plant. Each is a form of THC (tetrahydrocannabinol), which is primarily responsible for marijuana's psychoactive effects.
Each of the cannabinoids can produce a "high" effect, but they all work a little differently.
Delta 8 is found in trace amounts of the cannabis plant, as it's produced when a cannabis plant ages, according to Leafwell, an online marijuana resource.
Because cannabis plants only produce a small amount of Delta 8, most Delta 8 products contain a synthesized form of the cannabinoid, which is made by rearranging the molecules of CBD (cannabidiol), according to Leafwell.
Delta 9 is the most abundant cannabinoid in marijuana. Discussions about medical and recreational marijuana, which are regulated at the state level, are about Delta 9.
Like Delta 8, Delta 10 is a trace cannabinoid in the cannabis plant. It is also often produced in a lab from CBD.
Though each of the cannabinoids may have different affects on the body, each interacts with the body's endocannabinoid system, which regulates bodily functions like mood, pain, sleep, appetite, memory, and reproduction and fertility, according to Healthline.
Delta 9 attaches to the body's endocannabinoid system more strongly than Delta 8 and Delta 10, meaning its effects are more potent, according to Leafwell. Users may feel a more intense high with Delta 9.
Delta 8 and Delta 10 are often available over the counter at convenience stores, smoke and vape shops and gas stations. Delta 9 is only available for purchase from licensed medical and adult-use marijuana dispensaries in states where marijuana is legal.
Age restrictions on purchasing THC products vary per state, but commonly consumers must be 18 or 21 to purchase products that contain Delta 8, 9 or 10.
Delta 8 and Delta 10 are both federally legal, as they are derived from hemp and contain low traces of THC. They are protected under the Farm Bill signed by Trump during his first term in 2018. However, some states have banned the sale and consumption of both Delta 8 and 10, citing health concerns.
Delta 9 is not federally legal but regulated on a state-by-state basis.
More: Where is marijuana legal in the US? Here's which states have legalized weed as 4/20 approaches
Yes, each of the cannabinoids can show up on a drug test. However, more commercial drug tests cannot differentiate between the cannabinoids, according to WedMD.
Historically, hemp, including Delta 8 and Delta 10, have not been as regulated or well researched as Delta 9. Though Delta 8 and Delta 10 are derived from the natural cannabis plant, the Food and Drug Administration advises consumers to be cautious of products that contain these compounds.
For example, some Delta 8 and Delta 10 products may be labeled simply as "hemp products," which may mislead consumers who associate "hemp" with "non-psychoactive." Additionally, because Delta 8 and Delta 10 are largely unregulated, some manufacturers may use unsafe chemicals to make the compounds, the FDA warns.
By and large, adults should always start by educating themselves before consuming any form of marijuana or hemp product and purchase products from licensed and/or regulated facilities.
Greta Cross is a national trending reporter at USA TODAY. Story idea? Email her at gcross@usatoday.com.
This article originally appeared on USA TODAY: Delta 8, 9 and 10: What makes the cannabis compounds different?
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


NBC News
6 hours ago
- NBC News
Trump brings back Presidential Fitness Test
President Donald Trump signed an executive order Thursday afternoon reinstating the national fitness assessment implemented in public schools from 1956 until 2013. The Obama administration replaced the fitness test after the 2012-13 school year with the Presidential Youth Fitness Program, which focused more on individual health than athletic prowess. NBC News' Tom Llamas speaks with Dr. Jordan Metzl about the 1, 2025
Yahoo
7 hours ago
- Yahoo
Trump doubles down on Most Favored Nation plan to target drug prices
US President Donald Trump has called on pharmaceutical manufacturers to lower US drug prices in line with the Most Favored Nation (MFN) policy first proposed in an executive order in May. On 31 July, the White House said letters were sent to leading pharmaceutical manufacturers like AstraZeneca, AbbVie, Eli Lilly, Regeneron, Novartis, Pfizer, and more, calling on them to take steps to lower drug prices in the US such that they match the lowest prices in other developed countries within the next 60 days. President Trump also shared many of these letters on the social media platform Truth Social. While this is not the first time the administration has floated the MFN policy, this time, the language used to address pharma companies is more aggressive. If the companies do not comply, the order states, the federal government 'will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices.' In response to this statement, a spokesperson for the industry body BIO said, 'We share the Administration's goal of ending foreign freeloading on American innovation. But importing socialist price controls would lead only to fewer new medicines and the rationing of healthcare for Americans and would strengthen and embolden foreign adversaries whose goal is to dominate the world in biotechnology.' The BIO spokesperson said eliminating the middlemen, ending the abuse of drug reimbursement programs like 340B would be a way to simplify the system, protect patients and narrow the pricing gap between the US and other developed countries. 'Middlemen' or pharmacy benefit managers (PBMs) are often blamed by the pharmaceutical companies for high drug prices. PBMs on their part have said they negotiate with different stakeholders to drive down costs, and pass on savings obtained through rebates and discounts to health plans. The letter to the manufacturers implores them to provide drug at 'MFN rates' to all Medicaid patients, and commit to providing these prices for newly launched drugs to all major US buyers like Medicare and commercial plans. The latest announcement also calls on drug manufacturers to opt in for platforms where drugs can be sold directly to patients at prices that are comparable to those in developed nations, which are currently offered to third party payers. Among the letters posted on Truth Social, Trump directly called on several CEOs like Albert Bourla of Pfizer, and Leonard Schleifer of Regeneron, by using their first names instead of a formal address. Several countries use international reference pricing as a strategy in their health systems. However, chief among the criticism following the May executive order has been the lack of details. Industry experts have highlighted a lack of clarity on how any potential list price changes will affect the prices patients pay at the pharmacy counter given the complex dynamics and multiple stakeholders in the US healthcare system. There is also a concern that if the US implements reference pricing, it could influence when companies choose to launch drugs in certain ex-US markets to avoid those potentially lower prices from being used as references. Furthermore, pharma companies have chosen the litigation route to fight legislative changes targeting drug prices, like the Inflation Reduction Act, and the same could be seen with the MFN executive order, as per a Bank of America report. "Trump doubles down on Most Favored Nation plan to target drug prices" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. 登入存取你的投資組合


Fox News
7 hours ago
- Fox News
The Presidential Fitness Test will help 'motivate kids,' says WWE's 'Triple H'
WWE CCO Paul 'Triple H' Levesque discusses President Donald Trump reinstating the Presidential Fitness Test and explains why he believes physical well-being is so important on 'The Ingraham Angle.'